Puriblood Medical Co., Ltd. (TPEX:6847)

Taiwan · Delayed Price · Currency is TWD

72.80

-2.10 (-2.80%)

Sep 8, 2026, 2:22 PM CST

Market Cap	1.03B -4.6%
Revenue (ttm)	80.54M -31.4%
Net Income	-55.81M
EPS	-3.92
Shares Out	14.23M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,936
Open	72.80
Previous Close	74.90
Day's Range	72.80 - 72.80
52-Week Range	47.75 - 93.70
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Puriblood Medical

Puriblood Medical Co., Ltd. engages in the research and development of blood purification-related medical devices in Taiwan and internationally. The company offers leukoreduction, cell separation, and P-Tex, an anti-fouling technology, which is composed by bio-inspired molecular formula. It is also involved in animal blood transfusion. Puriblood Medical Co., Ltd. was incorporated in 2015 and is based in Hsinchu City, Taiwan. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2015

Employees 38

Stock Exchange Taipei Exchange

Ticker Symbol 6847

Full Company Profile

Financial Performance

In 2025, Puriblood Medical's revenue was 82.34 million, a decrease of -25.61% compared to the previous year's 110.67 million. Losses were -39.00 million, 626.7% more than in 2024.

Financial Statements